These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37815053)

  • 21. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Soedamah-Muthu SS; Chang YF; Otvos J; Evans RW; Orchard TJ;
    Diabetologia; 2003 May; 46(5):674-82. PubMed ID: 12743701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease.
    Freedman DS; Otvos JD; Jeyarajah EJ; Barboriak JJ; Anderson AJ; Walker JA
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1046-53. PubMed ID: 9672064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
    Ference BA; Kastelein JJP; Ray KK; Ginsberg HN; Chapman MJ; Packard CJ; Laufs U; Oliver-Williams C; Wood AM; Butterworth AS; Di Angelantonio E; Danesh J; Nicholls SJ; Bhatt DL; Sabatine MS; Catapano AL
    JAMA; 2019 Jan; 321(4):364-373. PubMed ID: 30694319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein E in VLDL and LDL with apolipoprotein C-III is associated with a lower risk of coronary heart disease.
    Mendivil CO; Rimm EB; Furtado J; Sacks FM
    J Am Heart Assoc; 2013 May; 2(3):e000130. PubMed ID: 23672999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
    Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K
    Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies.
    Joshi PH; Khokhar AA; Massaro JM; Lirette ST; Griswold ME; Martin SS; Blaha MJ; Kulkarni KR; Correa A; D'Agostino RB; Jones SR; Toth PP;
    J Am Heart Assoc; 2016 Apr; 5(5):. PubMed ID: 27130348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol.
    Björnson E; Adiels M; Gummesson A; Taskinen MR; Burgess S; Packard CJ; Borén J
    J Am Coll Cardiol; 2024 Oct; 84(14):1328-1338. PubMed ID: 39322327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women.
    Mora S; Otvos JD; Rosenson RS; Pradhan A; Buring JE; Ridker PM
    Diabetes; 2010 May; 59(5):1153-60. PubMed ID: 20185808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women.
    Furusyo N; Ai M; Okazaki M; Ikezaki H; Ihara T; Hayashi T; Hiramine S; Ura K; Kohzuma T; Schaefer EJ; Hayashi J
    Atherosclerosis; 2013 Dec; 231(2):238-45. PubMed ID: 24267234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid profile, lipid ratios, apolipoproteins, and risk of cardiometabolic multimorbidity in men: The Kuopio Ischaemic Heart Disease Risk Factor Study.
    Tajik B; Voutilainen A; Kauhanen J; Mazidi M; Lip GYH; Tuomainen TP; Isanejad M
    Lipids; 2022 Mar; 57(2):141-149. PubMed ID: 35049039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in very low density, low density, and high density lipoproteins in surgically postmenopausal women.
    Chiuve SE; Martin LA; Campos H; Sacks FM
    J Clin Endocrinol Metab; 2004 May; 89(5):2207-13. PubMed ID: 15126543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol.
    Lawler PR; Akinkuolie AO; Chu AY; Shah SH; Kraus WE; Craig D; Padmanabhan L; Glynn RJ; Ridker PM; Chasman DI; Mora S
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28733430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of apolipoprotein B to cholesterol in low density lipoproteins of patients with coronary heart disease.
    Vega GL; Grundy SM
    J Lipid Res; 1984 Jun; 25(6):580-92. PubMed ID: 6747462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations of resting heart rate with concentrations of lipoprotein subfractions in sedentary men.
    Williams PT; Haskell WL; Vranizan KM; Blair SN; Krauss RM; Superko HR; Albers JJ; Frey-Hewitt B; Wood PD
    Circulation; 1985 Mar; 71(3):441-9. PubMed ID: 3918806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissociation of high density lipoprotein precursors from apolipoprotein B-containing lipoproteins in the presence of unesterified fatty acids and a source of apolipoprotein A-I.
    Musliner TA; Long MD; Forte TM; Nichols AV; Gong EL; Blanche PJ; Krauss RM
    J Lipid Res; 1991 Jun; 32(6):917-33. PubMed ID: 1940624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study.
    Parish S; Offer A; Clarke R; Hopewell JC; Hill MR; Otvos JD; Armitage J; Collins R;
    Circulation; 2012 May; 125(20):2469-78. PubMed ID: 22539783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content.
    Marston NA; Giugliano RP; Melloni GEM; Park JG; Morrill V; Blazing MA; Ference B; Stein E; Stroes ES; Braunwald E; Ellinor PT; Lubitz SA; Ruff CT; Sabatine MS
    JAMA Cardiol; 2022 Mar; 7(3):250-256. PubMed ID: 34773460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.
    Brunzell JD; Albers JJ; Chait A; Grundy SM; Groszek E; McDonald GB
    J Lipid Res; 1983 Feb; 24(2):147-55. PubMed ID: 6403642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction.
    Hamsten A; Walldius G; Szamosi A; Dahlen G; de Faire U
    Circulation; 1986 Jun; 73(6):1097-110. PubMed ID: 3698244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein subclasses and coronary artery calcium in postmenopausal women from the healthy women study.
    Mackey RH; Kuller LH; Sutton-Tyrrell K; Evans RW; Holubkov R; Matthews KA
    Am J Cardiol; 2002 Oct; 90(8A):71i-76i. PubMed ID: 12419483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.